Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for prevention of remifentanil-associated postoperative hyperalgesia after laparoscopic cholecystectomy
ChiCTR1800020209Phase 4Recruiting
- Sponsor
- Tongling People's Hospital
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine and remifentanil in Postoperative hyperalgesia (4 arms), sponsored by Tongling People's Hospital. Primary endpoints: VAS score and Postoperative shivering. Started Jan 2019; status: recruiting.
02
Drugs
nalbuphineremifentanil
03
Conditions
Postoperative hyperalgesia
Beyond the preview
Go deeper on ChiCTR1800020209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020209.